The Potential Importance of MicroRNAs as Novel Indicators How to Manage Patients with Juvenile Idiopathic Arthritis More Effectively

J Immunol Res. 2021 Jan 28:2021:9473508. doi: 10.1155/2021/9473508. eCollection 2021.

Abstract

Small, noncoding sequences of ribonucleic acid called microRNAs (miRNAs, miR) are functioning as posttranscriptional regulators of gene expression. As they draw increasing attention of rheumatologists, there is a growing body of evidence concerning specific molecules that may affect the long-term care of patients with inflammatory arthritides. Findings involving children with juvenile idiopathic arthritis (JIA) are still limited though. The aim of the study was to browse the available data on microRNAs which may be utilized as potential biomarkers helpful in diagnosing and monitoring JIA patients. The review contains a brief summary on the most studied sequences: miR-16, miR-125a-5p, miR-146a, miR-155, and miR-223. It is complemented with other miRNAs possibly relevant for JIA (miR-145, miR-23b, miR-27a, and miR-204) and discussion on challenges for using miRNAs in pediatric rheumatology (particularly, issues regarding specificity of biomarkers and measurements involving synovial fluid).

Publication types

  • Review

MeSH terms

  • Arthritis, Juvenile / diagnosis*
  • Arthritis, Juvenile / genetics*
  • Biomarkers*
  • Clinical Decision-Making
  • Disease Management
  • Disease Susceptibility
  • Gene Expression Regulation
  • Humans
  • MicroRNAs / genetics*

Substances

  • Biomarkers
  • MicroRNAs